- Home
- SGHT vs VTN Comparison
SGHT vs VTN Comparison
Compare SGHT & VTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- VTN
- Stock Information
- Founded
- SGHT 2011
- VTN 1992
- Country
- SGHT United States
- VTN United States
- Employees
- SGHT N/A
- VTN N/A
- Industry
- SGHT Medical Specialities
- VTN Finance Companies
- Sector
- SGHT Health Care
- VTN Finance
- Exchange
- SGHT Nasdaq
- VTN Nasdaq
- Market Cap
- SGHT 193.2M
- VTN 163.5M
- IPO Year
- SGHT 2021
- VTN N/A
- Fundamental
- Price
- SGHT $5.24
- VTN $10.88
- Analyst Decision
- SGHT Buy
- VTN
- Analyst Count
- SGHT 8
- VTN 0
- Target Price
- SGHT $4.50
- VTN N/A
- AVG Volume (30 Days)
- SGHT 221.6K
- VTN 41.7K
- Earning Date
- SGHT 11-06-2025
- VTN 01-01-0001
- Dividend Yield
- SGHT N/A
- VTN 3.74%
- EPS Growth
- SGHT N/A
- VTN N/A
- EPS
- SGHT N/A
- VTN 0.16
- Revenue
- SGHT $76,303,000.00
- VTN N/A
- Revenue This Year
- SGHT N/A
- VTN N/A
- Revenue Next Year
- SGHT $12.04
- VTN N/A
- P/E Ratio
- SGHT N/A
- VTN $67.06
- Revenue Growth
- SGHT N/A
- VTN N/A
- 52 Week Low
- SGHT $2.03
- VTN $8.49
- 52 Week High
- SGHT $5.52
- VTN $10.81
- Technical
- Relative Strength Index (RSI)
- SGHT 76.45
- VTN 46.46
- Support Level
- SGHT $3.22
- VTN $10.80
- Resistance Level
- SGHT $5.32
- VTN $11.39
- Average True Range (ATR)
- SGHT 0.31
- VTN 0.13
- MACD
- SGHT 0.22
- VTN -0.06
- Stochastic Oscillator
- SGHT 93.93
- VTN 15.02
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About VTN Invesco Trust for Investment Grade New York Municipals
Invesco Trust For Investment Grade New York Municipals is a diversified closed-end management investment company. Its objective is to provide common shareholders with a high level of current income exempt from federal as well as from New York State and New York City income taxes, consistent with preservation of capital.